US 10494440
Use of semaphorin-4D binding molecules to promote neurogenesis following stroke
granted A61KA61K2039/505A61P
Quick answer
US patent 10494440 (Use of semaphorin-4D binding molecules to promote neurogenesis following stroke) held by VACCINEX, INC. expires Mon Nov 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- VACCINEX, INC.
- Grant date
- Tue Dec 03 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K2039/505, A61P, A61P25/00, A61P25/08